Prognostic correlation of HLA-DR expression in large cell lymphoma as determined by LN3 antibody staining. An eastern cooperative oncology group (ECOG) study (Q67670940)

From Wikidata

Jump to navigation Jump to search

scientific article published on September 15, 1990

Language	Label	Description	Also known as
English	Prognostic correlation of HLA-DR expression in large cell lymphoma as determined by LN3 antibody staining. An eastern cooperative oncology group (ECOG) study	scientific article published on September 15, 1990

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1698115%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

Prognostic correlation of HLA-DR expression in large cell lymphoma as determined by LN3 antibody staining. An Eastern Cooperative Oncology Group (ECOG) study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1698115%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

Prognostic correlation of HLA-DR expression in large cell lymphoma as determined by LN3 antibody staining. An eastern cooperative oncology group (ECOG) study (English)

1 reference

10.1002/1097-0142(19900915)66:6<1147::AID-CNCR2820660612>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(19900915)66:6%3C1147::AID-CNCR2820660612%3E3.0.CO;2-Z

1 November 2022

1 reference

10.1002/1097-0142(19900915)66:6<1147::AID-CNCR2820660612>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(19900915)66:6%3C1147::AID-CNCR2820660612%3E3.0.CO;2-Z

1 November 2022

author name string

J. C. O'Keane

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1698115

1 November 2022

C. Mack

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1698115

1 November 2022

E. Lynch

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1698115

1 November 2022

D. Harrington

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1698115

1 November 2022

R. S. Neiman

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1698115

1 November 2022

language of work or name

0 references

publication date

1 September 1990

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1698115%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

15 September 1990

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1698115

1 November 2022

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19900915)66:6%3C1147::AID-CNCR2820660612%3E3.0.CO;2-Z

1 reference

10.1002/1097-0142(19900915)66:6<1147::AID-CNCR2820660612>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(19900915)66:6%3C1147::AID-CNCR2820660612%3E3.0.CO;2-Z

1 November 2022

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19900915)66:6%3C1147::AID-CNCR2820660612%3E3.0.CO;2-Z

1 reference

10.1002/1097-0142(19900915)66:6<1147::AID-CNCR2820660612>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(19900915)66:6%3C1147::AID-CNCR2820660612%3E3.0.CO;2-Z

1 November 2022

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1698115%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

66

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1698115%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1698115%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

1147-1153

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1698115%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

1

1 reference

10.1002/1097-0142(19900915)66:6<1147::AID-CNCR2820660612>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(19900915)66:6%3C1147::AID-CNCR2820660612%3E3.0.CO;2-Z

1 November 2022

Journal of Clinical Oncology

6

4

author name string

O'Connell

publication date

1986

1 reference

10.1002/1097-0142(19900915)66:6<1147::AID-CNCR2820660612>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(19900915)66:6%3C1147::AID-CNCR2820660612%3E3.0.CO;2-Z

1 November 2022

Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphoma

7

1 reference

10.1002/1097-0142(19900915)66:6<1147::AID-CNCR2820660612>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(19900915)66:6%3C1147::AID-CNCR2820660612%3E3.0.CO;2-Z

1 November 2022

Chemotherapy followed by consolidation radiation therapy for the treatment of clinical stage II aggressive histologic type non-Hodgkin's lymphoma

8

1 reference

10.1002/1097-0142(19900915)66:6<1147::AID-CNCR2820660612>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(19900915)66:6%3C1147::AID-CNCR2820660612%3E3.0.CO;2-Z

1 November 2022

Nonparametric Estimation from Incomplete Observations

10

1 reference

10.1002/1097-0142(19900915)66:6<1147::AID-CNCR2820660612>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(19900915)66:6%3C1147::AID-CNCR2820660612%3E3.0.CO;2-Z

1 November 2022

HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma

12

1 reference

10.1002/1097-0142(19900915)66:6<1147::AID-CNCR2820660612>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(19900915)66:6%3C1147::AID-CNCR2820660612%3E3.0.CO;2-Z

1 November 2022

Identifiers

10.1002/1097-0142(19900915)66:6<1147::AID-CNCR2820660612>3.0.CO;2-Z

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1698115%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1698115%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67670940&oldid=1762410181"